| History of lung transplantation
G. Massard (Strasbourg, France) | | | |  | |  |  | | | |
|
| The key elements of a lung transplant programme
P.A. Corris (Newcastle Upon Tyne, UK) | | | | | | | | | | |
|
| Referral guidelines (general principles and specific issues in CF, ILD, COPD and PH)
A. Boehler (Zurich, Switzerland) | | | | | | | | | | |
|
| Candidate selection: specific controversial issues (previous malignancies and chronic infections)
P.A. Corris (Newcastle Upon Tyne, UK) | | | | | | | | | | |
|
| Pre-surgical management of lung transplant candidates (from clinical to psychological approaches)
J. Gottlieb (Hanover, Germany) | |  | | | | | | | | |
|
| Lung transplant bridge with extracorporeal devices (ECMO and Novalung)  (1 grade, 0 comment)
M. Strüber (Hanover, Germany) | | | | | | | | | | |
|
| Mechanical ventilation in lung transplant recipients
D.E. Van Raemdonck (Leuven, Belgium) | | | | | | | | | | |
|
| Identifying usable donor organs : pushing the boundaries
G. Massard (Strasbourg, France) | | | | | | | | | | |
|
| Non heart beating donors: principles, regulations, ethical issues, and results
E.M.A. Verschuuren (Groningen, The Netherlands) | | | | | | | | | | |
|
| Which donor features can affect graft outcome?
E.M.A. Verschuuren (Groningen, The Netherlands) | | | | | | | | | | |
|
| Increasing donation rates: lessons within Europe
P. Thomas (Marseille, France) | | | | | | | | | | |
|
| Ex vivo donor lung perfusion
A. Fisher (Newcastle Upon Tyne, UK) | | | | | | | | | | |
|
| How to perform a lung transplant
G. Massard (Strasbourg, France) | | | | | | | | | | |
|
| Pathophysiology and classification of PGD
D.E. Van Raemdonck (Leuven, Belgium) | | | | | | | | | | |
|
| New perspectives in PGD prevention and treatment
J. Gottlieb (Hanover, Germany) | | | | | | | | | | |
|
| Management of post-transplant airway complications
G. Massard (Strasbourg, France) | | | | | | | | | | |
|
| Acute cellular and humoral rejection
F. Meloni (Pavia, Italy) | | | | | | | | | | |
|
| Bronchoscopic monitoring after lung transplantation: actual role of TBB and BAL
A. Boehler (Zurich, Switzerland) | | | | | | | | | | |
|
| Challenges in post transplant lung pathology
J. Gottlieb (Hanover, Germany) | | | | | | | | | | |
|
| Hot Topics in Transplant Ethics
P.A. Corris (Newcastle Upon Tyne, UK) | | | | | | | | | | |
|
| Old and new strategies in induction therapy
A. Boehler (Zurich, Switzerland) | | | | | | | | | | |
|
| Calcineurin inhibitors: friend and foe?
M. Iversen (Copenhagen, Denmark) | | | | | | | | | | |
|
| Newer immunosuppressants: MMF and mTor inhibitors
P.A. Corris (Newcastle Upon Tyne, UK) | | | | | | | | | | |
|
| Actual role of azithromycin: when and how
G.M. Verleden (Leuven, Belgium) | | | | | | | | | | |
|
| CMV management in lung transplant recipients (1 grade, 0 comment)
E.M.A. Verschuuren (Groningen, The Netherlands) | | | | | | | | | | |
|
| Respiratory viral infections
F. Meloni (Pavia, Italy) | | | | | | | | | | |
|
| Aspergillus and other fungi
G.M. Verleden (Leuven, Belgium) | | | | | | | | | | |
|
| Multiresistant bacterial infections
A. Fisher (Newcastle Upon Tyne, UK) | | | | | | | | | | |
|
| 1st successful lung TX in Szczecin, Poland (1 grade, 0 comment)
B. Kubisa, (Szczecin, Poland) | | | | | | | | | | |
|
| BOS/OB: aetiology and pathogenesis
M. Iversen (Copenhagen, Denmark) | | | | | | | | | | |
|
| BOS sub-phenotyping: beyond lung function
G.M. Verleden (Leuven, Belgium) | | | | | | | | | | |
|
| Diagnosing and managing BOS/OB
A. Fisher (Newcastle Upon Tyne, UK) | | | | | | | | | | |
|
| Old and new therapeutic options in BOS
A. Boehler (Zurich, Switzerland) | | | | | | | | | | |
|
| Retransplantation for graft failure: indications, outcomes and ethical issues
G. Massard (Strasbourg, France) | | | | | | | | | | |
|
| Assessemnt and treatment of GER
F. Meloni (Pavia, Italy) | | | | | | | | | | |
|
| Renal dysfunction and cardiovascular disorders
M. Iversen (Copenhagen, Denmark) | | | | | | | | | | |
|
| Lymphoproliferative disease: prevention and management
E.M.A. Verschuuren (Groningen, The Netherlands) | | | | | | | | | | |
|
| Other malignancies: prevention and treatment
F. Meloni (Pavia, Italy) | | | | | | | | | | |
|